Skip to main content

Table 2 Relation between pathology with lesions’ characteristics

From: Interobserver agreement for the Vesical Imaging-Reporting and Data System (VI-RADS) in differentiating non-muscle-invasive and muscle-invasive urinary bladder tumors

 

Pathology

Test value

P value

Sig.

Non-muscle invasive

Muscle invasive

No. = 12

No. = 31

Location of lesions

 Neck

0 (0.0%)

2 (6.5%)

0.812*

0.368

NS

 Trigone

1 (8.3%)

3 (9.7%)

0.019*

0.892

NS

 Dome

1 (8.3%)

5 (16.1%)

0.438*

0.508

NS

 Anterior wall

1 (8.3%)

4 (12.9%)

0.176*

0.675

NS

 Posterior wall

3 (25.0%)

1 (3.2%)

4.862*

0.027

S

 Lateral walls

4 (33.3%)

16 (51.6%)

1.162*

0.281

NS

 Circumferential

0 (0.0%)

5 (16.1%)

2.190*

0.139

NS

 Ureteral orifice

1 (8.3%)

3 (9.7%)

0.019*

0.892

NS

Size

 < 3 cm

6 (50.0%)

5 (16.1%)

5.213*

0.022

S

 ≥ 3 cm

6 (50.0%)

26 (83.9%)

Tumor contact length (TCL) (cm)

 Median (IQR)

2.9 (1.65–3.75)

5 (3.8–7.6)

− 2.682 ≠ 

0.007

HS

 Range

1.4–8.2

1.1–16

Stalk

 No

2 (16.7%)

30 (96.8%)

29.162*

0.000

HS

 Yes

10 (83.3%)

1 (3.2%)

 

ADC value (× 10−3 mm2/s)

 Mean ± SD

1.03 ± 0.28

1.03 ± 0.23

0.028•

0.978

NS

 Range

0.68–1.7

0.59–1.5

T stage

 < T3

12 (100.0%)

1 (3.2%)

38.412*

0.000

HS

 ≥ T3

0 (0.0%)

30 (96.8%)

  1. P value > 0.05: Nonsignificant; P value < 0.05: Significant; P value < 0.01: Highly significant
  2. *Chi-square test; •: Independent t test; ≠ : Mann–Whitney test